# Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke

> **NCT03552354** · PHASE4 · COMPLETED · sponsor: **General Hospital of Shenyang Military Region** · enrollment: 120 (actual)

## Conditions studied

- Stroke, Ischemic

## Interventions

- **DRUG:** Argatroban plus dual antiplatelet

## Key facts

- **NCT ID:** NCT03552354
- **Lead sponsor:** General Hospital of Shenyang Military Region
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-25
- **Primary completion:** 2018-10-08
- **Final completion:** 2019-01-08
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2020-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03552354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03552354, "Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03552354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*